0 Commentaires
0 Parts
3 Vue
0 Aperçu
Rechercher
Découvrez de nouvelles personnes, créer de nouvelles connexions et faire de nouveaux amis
-
Connectez-vous pour aimer, partager et commenter!
-
Large Molecule Drug Substance CDMO Market: The Future of Outsourced Biologics DevelopmentThe global Large Molecule Drug Substance CDMO Market is shaped by changing industry requirements and the level of demand across its key applications. Polaris Market Research has prepared this report to provide an overview of the industry and its expected development over the coming years. It looks at the factors that influence market activity and explains how revenue is spread across different...0 Commentaires 0 Parts 11 Vue 0 Aperçu
-
Healthcare Contract Development and Manufacturing Organization Market Forecast Shows Strong Industry ExpansionA new medicine does not reach the market through research alone. Between discovering a promising compound and producing a commercially available therapy lies a long chain of development, testing, formulation, manufacturing, quality control, regulatory work, and supply management. As pharmaceutical and biotechnology companies build increasingly complex pipelines, many are choosing not to develop...0 Commentaires 0 Parts 3KB Vue 0 Aperçu
-
Global Biopharmaceutical and Bio-CDMO Market Growing at 14.2% CAGR Through 2032According to a new report from Intel Market Research, the global Biopharmaceutical and Bio-CDMO market was valued at USD 25.71 billion in 2024 and is projected to grow from USD 28.95 billion in 2025 to USD 63.88 billion by 2032, exhibiting a robust CAGR of 14.2% during the forecast period (2025–2032). This growth is driven by increasing demand for biologics and biosimilars due to their...0 Commentaires 0 Parts 4KB Vue 0 Aperçu
-
Pharmaceutical Manufacturing Market Growth: Key Opportunities for Industry PlayersPharmaceutical Manufacturing Market to Reach USD 1,318.3 Billion by 2033 Overview According to the supplied market estimates, the global Pharmaceutical Manufacturing Market is projected to grow from USD 557.6 billion in 2025 to USD 1,318.3 billion by 2033, registering a compound annual growth rate (CAGR) of 11.8%. This growth reflects increasing pharmaceutical demand, technological...0 Commentaires 0 Parts 590 Vue 0 Aperçu
-
United States Sterile Fill-Finish for Cell and Gene Therapies Market Growing at 8.9%According to a new report from Intel Market Research, the United States Sterile Fill-Finish for Cell and Gene Therapies Market was valued at USD 0.54 billion in 2025 and is projected to reach USD 1.04 billion by 2034, growing at a robust CAGR of 8.9% during the forecast period (2025–2034). This expansion is driven by accelerating investments in cell‑and‑gene therapy pipelines, supportive...0 Commentaires 0 Parts 3KB Vue 0 Aperçu